– The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. – MAGNA™ is set to unlock the field of dynamic genomics. – Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life […]

Bellinzona, Switzerland – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists. BigOmics raised $1.42 million on the first closing of […]

BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) announced today that it has completed a new private placement of 10-year senior notes in the aggregate principal amount of $500 million to enhance its financial flexibility and fund strategic growth objectives. Gerald Herman, Bruker’s Executive Vice President & Chief Financial Officer, commented “This new debt financing capitalizes […]

MONTREAL & BOSTON — Nomic Bio (“Nomic”), the protein profiling company, today announced the closing of an oversubscribed US$17 million Series A funding round, bringing the company’s total funding to date to over US$21 million. The round was led by Lux Capital and joined by SR One and Casdin Capital, with participation from prior institutional investors. […]

GHENT, BELGIUM — Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert genetic material into cells. This genetic modification of cells is essential in, for example, cell therapy – an anti-cancer treatment that has become an integral part of modern medicine. Trince has raised EUR 4 million from Novalis […]

ArgusEye is a spin-off company from Linköping University, Sweden. The company’s scienBfic idea is based on extensive research into the combinaBon of nanoplasmonic detecBon and fiber opBcs for integrated biodetecBon The technology’s flexible design can be adapted for use across a variety of potenBal applicaBon areas, including conBnuous automaBzed bioprocessing (Industry 4.0) Stockholm — Eir […]

Plans for Near-Term Commercialization of its Proteomics and Multi-Omics System BOSTON — NanoMosaic Inc., a Tiger Gene founded company that has established itself as the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and multi-omics applications, announced today that it has closed an oversubscribed $40,750,000 Series A round of financing led by RA Capital […]

Effective at the open of market trading today, the Company will begin trading as Azenta, Inc. (Nasdaq: AZTA) CHELMSFORD, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or the “Company”) announced today that it has completed its previously announced corporate name change from “Brooks Automation, Inc.” to “Azenta, Inc.” In conjunction with the corporate name change, the Company […]